13F HOLDINGS REPORT
DCVC Opportunity Fund II GP, LLC
Quarter ended Q4 2024 · Filed February 14, 2025 · Accession 0001104659-25-013461
Total Value
$113.0M
Positions
2
Other Managers
0
Confidential Omitted
No
Holdings (2)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Rocket Lab USA, Inc. | RKLB | 3,388,249 | $86.3M | 76.36% |
| 2 | Recursion Pharmaceuticals, Inc. | RXRX | 3,951,141 | $26.7M | 23.64% |